Operating Expenses Summary of LIWANLI Innovation Co., Ltd.

LIWANLI Innovation Co., Ltd.'s latest annual operating expenses in 2023 was 54.86 Million TWD , up 6.45% from previous year.
LIWANLI Innovation Co., Ltd.'s latest quarterly operating expenses in 2024 Q2 was 14.29 Million TWD , up 10.07% from previous quarter.
LIWANLI Innovation Co., Ltd. reported a annual operating expenses of 51.54 Million TWD in annual operating expenses 2022, down -8.26% from previous year.
LIWANLI Innovation Co., Ltd. reported a annual operating expenses of 56.17 Million TWD in annual operating expenses 2021, down -31.96% from previous year.
LIWANLI Innovation Co., Ltd. reported a quarterly operating expenses of 14.29 Million TWD for 2024 Q2, up 10.07% from previous quarter.
LIWANLI Innovation Co., Ltd. reported a quarterly operating expenses of 12.98 Million TWD for 2024 Q1, down -13.33% from previous quarter.

Annual Operating Expenses Chart of LIWANLI Innovation Co., Ltd. (2023 - 2009)

Historical Annual Operating Expenses of LIWANLI Innovation Co., Ltd. (2023 - 2009)

Year	Operating Expenses	Operating Expenses Growth
2023	54.86 Million TWD	6.45%
2022	51.54 Million TWD	-8.26%
2021	56.17 Million TWD	-31.96%
2020	82.57 Million TWD	4.7%
2019	78.86 Million TWD	16.7%
2018	67.58 Million TWD	-12.18%
2017	76.94 Million TWD	28.34%
2016	59.95 Million TWD	-44.78%
2015	108.57 Million TWD	-24.85%
2014	144.47 Million TWD	-13.03%
2013	166.11 Million TWD	30.82%
2012	126.98 Million TWD	31.73%
2011	96.39 Million TWD	28.1%
2010	75.25 Million TWD	-0.3%
2009	75.48 Million TWD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q3	15.65 Million TWD	-68.78%
2024 Q2	14.29 Million TWD	10.07%
2024 Q1	12.98 Million TWD	-13.33%
2023 Q3	12.98 Million TWD	-11.28%
2023 Q2	14.63 Million TWD	29.69%
2023 Q1	11.28 Million TWD	-13.16%
2023 FY	54.86 Million TWD	6.45%
2023 Q4	14.98 Million TWD	15.4%
2022 Q2	13.09 Million TWD	5.06%
2022 FY	51.54 Million TWD	-8.26%
2022 Q4	12.99 Million TWD	-0.05%
2022 Q1	12.46 Million TWD	-2.82%
2022 Q3	12.99 Million TWD	-0.71%
2021 FY	56.17 Million TWD	-31.96%
2021 Q1	16.18 Million TWD	-16.22%
2021 Q2	26.27 Million TWD	62.36%
2021 Q3	906 Thousand TWD	-96.55%
2021 Q4	12.82 Million TWD	1315.23%
2020 Q2	25.89 Million TWD	46.04%
2020 Q1	17.73 Million TWD	21.18%
2020 FY	82.57 Million TWD	4.7%
2020 Q4	19.31 Million TWD	-1.6%
2020 Q3	19.62 Million TWD	-24.22%
2019 FY	78.86 Million TWD	16.7%
2019 Q2	15.54 Million TWD	-44.53%
2019 Q3	20.66 Million TWD	32.93%
2019 Q1	28.02 Million TWD	120.91%
2019 Q4	14.63 Million TWD	-29.18%
2018 Q3	14.34 Million TWD	-19.07%
2018 Q2	17.71 Million TWD	-22.41%
2018 Q4	12.68 Million TWD	-11.54%
2018 FY	67.58 Million TWD	-12.18%
2018 Q1	22.83 Million TWD	17.91%
2017 Q4	19.36 Million TWD	-11.96%
2017 Q1	21.68 Million TWD	30.14%
2017 Q2	13.9 Million TWD	-35.88%
2017 Q3	21.99 Million TWD	58.24%
2017 FY	76.94 Million TWD	28.34%
2016 Q4	16.66 Million TWD	-11.82%
2016 Q1	12.5 Million TWD	-50.35%
2016 FY	59.95 Million TWD	-44.78%
2016 Q2	11.89 Million TWD	-4.93%
2016 Q3	18.89 Million TWD	58.88%
2015 Q1	30.96 Million TWD	16.88%
2015 FY	108.57 Million TWD	-24.85%
2015 Q4	25.19 Million TWD	-5.27%
2015 Q3	26.59 Million TWD	3.02%
2015 Q2	25.81 Million TWD	-16.63%
2014 Q4	26.49 Million TWD	-29.96%
2014 FY	144.47 Million TWD	-13.03%
2014 Q1	41.19 Million TWD	15.83%
2014 Q2	38.95 Million TWD	-5.44%
2014 Q3	37.82 Million TWD	-2.91%
2013 Q4	35.56 Million TWD	-30.83%
2013 FY	166.11 Million TWD	30.82%
2013 Q1	37.5 Million TWD	14.84%
2013 Q2	41.61 Million TWD	10.95%
2013 Q3	51.42 Million TWD	23.57%
2012 Q3	28.51 Million TWD	-5.23%
2012 Q1	30.95 Million TWD	-3.38%
2012 FY	126.98 Million TWD	31.73%
2012 Q4	32.66 Million TWD	14.56%
2012 Q2	30.08 Million TWD	-2.81%
2011 Q2	21.88 Million TWD	27.25%
2011 Q3	25.26 Million TWD	15.43%
2011 Q4	32.03 Million TWD	26.8%
2011 FY	96.39 Million TWD	28.1%
2011 Q1	17.2 Million TWD	16.03%
2010 Q2	19.16 Million TWD	7.27%
2010 FY	75.25 Million TWD	-0.3%
2010 Q3	23.4 Million TWD	22.16%
2010 Q1	17.86 Million TWD	0.0%
2010 Q4	14.82 Million TWD	-36.66%
2009 FY	75.48 Million TWD	0.0%

Peer Operating Expenses Comparison of LIWANLI Innovation Co., Ltd.

Name	Operating Expenses	Operating Expenses Difference
Grape King Bio Ltd	6.03 Billion TWD	99.092%
Standard Chem & Pharm CO., LTD.	1.46 Billion TWD	96.257%
Maywufa Company Ltd.	854.37 Million TWD	93.578%
ScinoPharm Taiwan, Ltd.	901.49 Million TWD	93.914%
Lotus Pharmaceutical Co., Ltd.	4.48 Billion TWD	98.776%
YungShin Global Holding Corporation	2.04 Billion TWD	97.321%
PhytoHealth Corporation	67.64 Million TWD	18.889%
SCI Pharmtech, Inc.	190.02 Million TWD	71.127%
Formosa Laboratories, Inc.	1.24 Billion TWD	95.605%
PharmaEssentia Corporation	4.49 Billion TWD	98.779%
Bora Pharmaceuticals Co., LTD.	1.74 Billion TWD	96.851%

Global Stocks Search

LIWANLI Innovation Co., Ltd. (3054.TW)

Operating Expenses Summary of LIWANLI Innovation Co., Ltd.

Annual Operating Expenses Chart of LIWANLI Innovation Co., Ltd. (2023 - 2009)

Historical Annual Operating Expenses of LIWANLI Innovation Co., Ltd. (2023 - 2009)

Peer Operating Expenses Comparison of LIWANLI Innovation Co., Ltd.